Cargando…

Using deep learning to identify bladder cancers with FGFR‐activating mutations from histology images

BACKGROUND: In recent years, the fibroblast growth factor receptor (FGFR) pathway has been proven to be an important therapeutic target in bladder cancer. FGFR‐targeted therapies are effective for patients with FGFR mutation, which can be discovered through genetic sequencing. However, genetic seque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velmahos, Constantine S., Badgeley, Marcus, Lo, Ying‐Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290253/ https://www.ncbi.nlm.nih.gov/pubmed/34114376 http://dx.doi.org/10.1002/cam4.4044

Ejemplares similares

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
por: Guancial, Elizabeth A, et al.
Publicado: (2014)

SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer
por: Lindgren, Maria Skydt, et al.
Publicado: (2021)

The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance of histology type and metastatic pattern
por: Wang, Ping, et al.
Publicado: (2020)

Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma
por: Li, Zhi‐Cheng, et al.
Publicado: (2018)

Bladder tumor ILC1s undergo Th17‐like differentiation in human bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2021)

Significance of the FGFR3 mutation in Chinese patients with bladder cancer
por: Hao, Lanxiang, et al.
Publicado: (2023)

Multimodal MR imaging signatures to identify brain diffuse midline gliomas with H3 K27M mutation
por: Su, Xiaorui, et al.
Publicado: (2021)

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
por: Garje, Rohan, et al.
Publicado: (2020)

Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models
por: Grünewald, Sylvia, et al.
Publicado: (2019)

FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
por: Foth, Mona, et al.
Publicado: (2018)

Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma
por: Fomchenko, Elena I., et al.
Publicado: (2021)

Segmental hypopigmented acneiform nevus with FGFR2 gene mutation()
por: Xie, Yongyi, et al.
Publicado: (2023)

Identifying transcriptomic correlates of histology using deep learning
por: Badea, Liviu, et al.
Publicado: (2020)

Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway
por: Chung, An‐Ko, et al.
Publicado: (2019)

Toward automatic prediction of EGFR mutation status in pulmonary adenocarcinoma with 3D deep learning
por: Zhao, Wei, et al.
Publicado: (2019)

Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing
por: Millholland, John M, et al.
Publicado: (2012)

FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures
por: Sridharan, Vishwajith, et al.
Publicado: (2022)

Deep learning with test-time augmentation for radial endobronchial ultrasound image differentiation: a multicentre verification study
por: Yu, Kai-Lun, et al.
Publicado: (2023)

The histological type of endometrial cancer is not associated with menopause status at diagnosis
por: Sun, Xinyi, et al.
Publicado: (2022)

A deep learning nomogram kit for predicting metastatic lymph nodes in rectal cancer
por: Ding, Lei, et al.
Publicado: (2020)

The role of deep learning‐based survival model in improving survival prediction of patients with glioblastoma
por: Moradmand, Hajar, et al.
Publicado: (2021)

FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
por: Klempner, Samuel J., et al.
Publicado: (2019)

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
por: Coukos, Alexander, et al.
Publicado: (2022)

Deep Learning Prediction of TERT Promoter Mutation Status in Thyroid Cancer Using Histologic Images
por: Kim, Jinhee, et al.
Publicado: (2023)

The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer
por: Gruhl, Joshua D., et al.
Publicado: (2020)

Deletion/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation‐dependent probe amplification
por: Bazrafshani, Mohammad Reza R., et al.
Publicado: (2015)

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
por: Zhang, Xiao‐Guang, et al.
Publicado: (2018)

Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma
por: Prawira, Aldo, et al.
Publicado: (2020)

GZD824 overcomes FGFR1‐V561F/M mutant resistance in vitro and in vivo
por: Jiang, Kaili, et al.
Publicado: (2021)

The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma
por: Jiang, Junjie, et al.
Publicado: (2020)

Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides
por: Zheng, Qingyuan, et al.
Publicado: (2022)

FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia
por: Ballester, Leomar Y., et al.
Publicado: (2018)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
por: Weickhardt, Andrew J., et al.
Publicado: (2022)

Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2‐FGFR1 autocrine loop
por: Cen, Mengyuan, et al.
Publicado: (2018)

Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas
por: Zhou, Yu‐Wen, et al.
Publicado: (2021)

The histological characteristics and clinical outcomes of lung cancer in patients with combined pulmonary fibrosis and emphysema
por: Zhang, Meng, et al.
Publicado: (2016)

Human papillomavirus and survival of patients per histological subsite of tonsillar squamous cell carcinoma
por: Haeggblom, Linnea, et al.
Publicado: (2018)

Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
por: Jogo, Tomoko, et al.
Publicado: (2021)

Deep learning pathological microscopic features in endemic nasopharyngeal cancer: Prognostic value and protentional role for individual induction chemotherapy
por: Liu, Kuiyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7kqf65cf2idsv7be06jll8nlpt